Drugs / SPARC1102
last change Sep 2011 re-read 3 minutes ago

SPARC1102

Developed for
conjunctivitis
Investigated by
Sun Pharma Advanced Research Company Limited

Trials 1

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01320553 Jun → Aug 2011 conjunctivitis Sun Pharma Advanced Research Company Limited Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SPARC1102 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01320553 ↗